Marathon Oil shareholders vote in favor of $16 bln ConocoPhillips deal-March 2024-www.financetom.com

Marathon Oil shareholders vote in favor of $16 bln ConocoPhillips deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Marathon Oil shareholders vote in favor of $16 bln ConocoPhillips deal

Aug 29, 2024 7:43 AM

HOUSTON, Aug 29 (Reuters) - Marathon Oil ( MRO )

shareholders on Thursday approved the U.S. oil producer's nearly

$16 billion acquisition by ConocoPhillips ( COP ), the company

said.

Marathon Oil ( MRO ) and ConocoPhillips ( COP ) expect the purchase, which

is undergoing a Federal Trade Commission review, to close late

in the fourth quarter of 2024. Details of the vote were not

immediately available.

Previous page： Tevogen Bio Signs Letter of Intent With CD8 Technology for R&D, Manufacturing Facility Next page： Boeing Eyes $20.7 Billion Windfall As Stock Offering Expands: Details

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Tevogen Bio Signs Letter of Intent With CD8 Technology for R&D, Manufacturing Facility

Nov 3, 2024

01:12 PM EDT, 10/29/2024 (MT Newswires) -- Tevogen Bio Holdings ( TVGN ) said Tuesday it has signed a letter of intent with CD8 Technology Services to build up to a $50 million facility for research and development and manufacturing. Tevogen said the project will not impact shareholder equity. The company's shares were down 7.9% in recent trading. Price: 2.53,...

Boeing Eyes $20.7 Billion Windfall As Stock Offering Expands: Details

Nov 3, 2024

The Boeing Company ( BA ) shares are trading higher on Tuesday. The company priced its public offerings at 112.5 million shares of common stock at $143.00 each and $5 billion in depositary shares. This represents a 1/20th interest in the new 6.00% Series A Mandatory Convertible Preferred Stock at $50.00 per share. Earlier, the company planned to offer 90...

Zai Lab's Schizophrenia Treatment KarXT Meets Primary Endpoint in Phase 3 Trial

Nov 3, 2024

01:10 PM EDT, 10/29/2024 (MT Newswires) -- Zai Lab ( ZLAB ) said Tuesday that a phase 3 trial evaluating the safety and efficacy of KarXT in patients with schizophrenia in China met its primary endpoint as it demonstrated a statistically significant reduction in Positive and Negative Syndrome Scale total score compared with placebo at week 5. The trial, which...

Market Chatter: Microsoft-backed OpenAI Drops Foundry Plans; Partners With Broadcom, TSMC to Build AI Chips

Nov 3, 2024

01:10 PM EDT, 10/29/2024 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is working with Broadcom ( AVGO ) and TSMC (TSM) to build a chip designed to support artificial intelligence systems, Reuters reported Tuesday, citing sources. The company behind ChatGPT had planned to build its own foundries to manufacture chips but has foregone those plans due to the...